Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected Adults
BACKGROUND AND OBJECTIVES: A Canadian group, consisting of six physicians and an HIV researcher with significant experience and knowledge in HIV management, reviewed the available data and developed guidelines for Canadian health care providers (who treat HIV infection) on the appropriate use of mar...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2010/303474 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561206301294592 |
|---|---|
| author | Anita Rachlis Marianne Harris Richard Lalonde Stephen D Shafran Cécile Tremblay Mark A Wainberg Sharon Walmsley |
| author_facet | Anita Rachlis Marianne Harris Richard Lalonde Stephen D Shafran Cécile Tremblay Mark A Wainberg Sharon Walmsley |
| author_sort | Anita Rachlis |
| collection | DOAJ |
| description | BACKGROUND AND OBJECTIVES: A Canadian group, consisting of six physicians and an HIV researcher with significant experience and knowledge in HIV management, reviewed the available data and developed guidelines for Canadian health care providers (who treat HIV infection) on the appropriate use of maraviroc (UK-427,857) in HIV-infected adults. |
| format | Article |
| id | doaj-art-29af8fad739743de85d6ffd669937723 |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-29af8fad739743de85d6ffd6699377232025-02-03T01:25:43ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322010-01-0121415917210.1155/2010/303474Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected AdultsAnita Rachlis0Marianne Harris1Richard Lalonde2Stephen D Shafran3Cécile Tremblay4Mark A Wainberg5Sharon Walmsley6Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, CanadaAIDS Research Program, St Paul’s Hospital, Vancouver, British Columbia, CanadaImmunodeficiency Service and Division of Infectious Diseases, McGill University Health Centre, Montreal, Quebec, CanadaDivision of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDepartment of Microbiology and Immunology, Centre Hospitalier de l’Université de Montréal, CanadaMcGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, CanadaDivision of Infectious Diseases, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, CanadaBACKGROUND AND OBJECTIVES: A Canadian group, consisting of six physicians and an HIV researcher with significant experience and knowledge in HIV management, reviewed the available data and developed guidelines for Canadian health care providers (who treat HIV infection) on the appropriate use of maraviroc (UK-427,857) in HIV-infected adults.http://dx.doi.org/10.1155/2010/303474 |
| spellingShingle | Anita Rachlis Marianne Harris Richard Lalonde Stephen D Shafran Cécile Tremblay Mark A Wainberg Sharon Walmsley Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected Adults Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected Adults |
| title_full | Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected Adults |
| title_fullStr | Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected Adults |
| title_full_unstemmed | Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected Adults |
| title_short | Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected Adults |
| title_sort | canadian consensus guidelines for the optimal use of maraviroc in the treatment of hiv infected adults |
| url | http://dx.doi.org/10.1155/2010/303474 |
| work_keys_str_mv | AT anitarachlis canadianconsensusguidelinesfortheoptimaluseofmaravirocinthetreatmentofhivinfectedadults AT marianneharris canadianconsensusguidelinesfortheoptimaluseofmaravirocinthetreatmentofhivinfectedadults AT richardlalonde canadianconsensusguidelinesfortheoptimaluseofmaravirocinthetreatmentofhivinfectedadults AT stephendshafran canadianconsensusguidelinesfortheoptimaluseofmaravirocinthetreatmentofhivinfectedadults AT ceciletremblay canadianconsensusguidelinesfortheoptimaluseofmaravirocinthetreatmentofhivinfectedadults AT markawainberg canadianconsensusguidelinesfortheoptimaluseofmaravirocinthetreatmentofhivinfectedadults AT sharonwalmsley canadianconsensusguidelinesfortheoptimaluseofmaravirocinthetreatmentofhivinfectedadults |